Skip to main content

Table 1 Comparison of baseline sociodemographic characteristics and comorbidities in the study population

From: HbA1c changes in a deprived population who followed or not a diabetes self-management programme, organised in a multi-professional primary care practice: a historical cohort study on 207 patients between 2017 and 2019

 

Exposed group

(n = 69)

Non-exposed group (n = 138)

p- value

Matching criteria and characteristics

 Sex (missing n = 0)

  

1.00

  -Female

44 (63.8%)

88 (63.8%)

 

  -Male

25 (36.2%)

50 (36.2%)

 

 Diabetes type (missing n = 0)

  

1.00

  -Type 1

3 (4.3%)

6 (4.3%)

 

  -Type 2

66 (95.7%)

132 (95.7%)

 

GP in the MPCP (missing n = 0)

62 (90.0%)

124 (90.0%)

1.00

Age in years (missing n = 0)

58 (± 12)

60 (± 14)

0.40

Age at diabetes diagnosis, in years (missing EG n = 1, NEG n = 11)

49 (± 12)

49 (± 13)

0.89

Diabetes known for < 1 year (missing EG n = 1, NEG n = 11)

13 (19.1%)

22 (17.3%)

0.75

Education level (missing EG n = 8, NEG n = 99)

 No schooling

2 (3.3%)

4 (10.3%)

0.16

 Primary

19 (31.1%)

10 (25.6%)

 

 Secondary (middle school, high school)

32 (52.5%)

15 (38.5%)

 

 Higher education

8 (13.1%)

10 (25.6%)

 

Socio-professional categories (missing EG n = 0, NEG n = 24)

 Farmers, craftsmen, shopkeepers

0 (0.0%)

0 (0.0%)

0.77

 Executives, higher intellectual professions

0 (0.0%)

2 (1.8%)

 

 Intermediate professions

3 (4.3%)

7 (6.1%)

 

 Employees

12 (17.4%)

26 (22.8%)

 

 Workers

9 (13.0%)

10 (8.8%)

 

 Retired

29 (42.0%)

43 (37.7%)

 

 Not in employmenta

16 (23.2%)

26 (22.8%)

 

LDD (missing = 0)

 Presence of an additional LDD

29 (42.0%)

57 (41.3%)

0.92

 Number of additional LDD

0.6 (± 0.9)

0.6 (± 0.8)

0.89

 LDD for cardiovascular disorders

10 (14.5%)

24 (17.4%)

0.59

 LDD for psychiatric disorders

10 (14.5%)

9 (6.5%)

0.06

 LDD for neoplasia

5 (7.2%)

15 (10.9%)

0.40

 LDD for respiratory disorders

4 (5.8%)

11 (8.0%)

0.57

 LDD for neurological disorders

6 (8.7%)

9 (6.5%)

0.57

 LDD for other disorders

7 (10.1%)

9 (6.5%)

0.36

Comorbidities

 Hypertension (missing EG n = 1, NEG n = 0)

46 (67.6%)

92 (66.7%)

0.89

 Dyslipidaemia (missing n = 0)

35 (50.7%)

72 (52.2%)

0.84

 Diabetic nephropathy (missing EG n = 2, NEG n = 0)

13 (19.4%)

25 (18.1%)

0.82

 Diabetic retinopathy (missing EG n = 4, NEG n = 0)

7 (10.8%)

8 (5.8%)

0.25

 BMI > 30 in kg/m2 (missing EG n = 2, NEG n = 19)

34 (50.7%)

56 (47.1%)

0.63

  1. Continuous variables are expressed as mean (± standard deviation) and compared with the Student’s t or Mann–Whitney Wilcoxon test
  2. Categorical variables are expressed as numbers (percentage) and compared with the Chi2 or Fisher’s exact test
  3. A p-value < 0.05 was considered significant
  4. BMI Body Mass Index, EG Exposed Group, LDD Long Duration Disease, MPCP Multi-professional Primary Care Practice, NEG Non-Exposed Group
  5. aUnemployed people who have never worked, military, students, others
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us